VOYA Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-38,137
| Closed | -$130K | – | 2612 |
|
|
2018
Q3 | $130K | Hold |
38,137
| – | – | ﹤0.01% | 2452 |
|
|
2018
Q2 | $143K | Hold |
38,137
| – | – | ﹤0.01% | 2452 |
|
|
2018
Q1 | $156K | Hold |
38,137
| – | – | ﹤0.01% | 2394 |
|
|
2017
Q4 | $177K | Hold |
38,137
| – | – | ﹤0.01% | 2387 |
|
|
2017
Q3 | $271K | Hold |
38,137
| – | – | ﹤0.01% | 2225 |
|
|
2017
Q2 | $276K | Buy |
38,137
+7,834
| +26% | +$49K | ﹤0.01% | 2211 |
|
|
2017
Q1 | $187K | Hold |
30,303
| – | – | ﹤0.01% | 2297 |
|
|
2016
Q4 | $178K | Sell |
30,303
-8,931
| -23% | -$48.8K | ﹤0.01% | 2330 |
|
|
2016
Q3 | $208 | Sell |
39,234
-2,565
| -6% | -$13.8K | ﹤0.01% | 2272 |
|
|
2016
Q2 | $277K | Hold |
41,799
| – | – | ﹤0.01% | 2072 |
|
|
2016
Q1 | $195K | Hold |
41,799
| – | – | ﹤0.01% | 2214 |
|
|
2015
Q4 | $211K | Hold |
41,799
| – | – | ﹤0.01% | 2248 |
|
|
2015
Q3 | $147K | Sell |
41,799
-12,901
| -24% | -$86.4K | ﹤0.01% | 2388 |
|
|
2015
Q2 | $546K | Hold |
54,700
| – | – | ﹤0.01% | 1859 |
|
|
2015
Q1 | $696K | Hold |
54,700
| – | – | ﹤0.01% | 1690 |
|
|
2014
Q4 | $774K | Hold |
54,700
| – | – | ﹤0.01% | 1627 |
|
|
2014
Q3 | $752K | Hold |
54,700
| – | – | ﹤0.01% | 1630 |
|
|
2014
Q2 | $841K | Hold |
54,700
| – | – | ﹤0.01% | 1616 |
|
|
2014
Q1 | $932K | Hold |
54,700
| – | – | ﹤0.01% | 1510 |
|
|
2013
Q4 | $708K | Hold |
54,700
| – | – | ﹤0.01% | 1701 |
|
|
2013
Q3 | $552K | Hold |
54,700
| – | – | ﹤0.01% | 1824 |
|
|
2013
Q2 | $409K | Buy |
+54,700
| New | +$427K | ﹤0.01% | 1994 |
|
VOYA Investment Management's KERX Position: Q4 2018 in Review
VOYA Investment Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 38,137 shares — an estimated $130K sold.
VOYA Investment Management first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $932K in Q1 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- VOYA Investment Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- VOYA Investment Management sold 38,137 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $130K.
- VOYA Investment Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- VOYA Investment Management's Keryx Biopharmaceuticals Inc position peaked at $932K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on VOYA Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.